Pertzye

Active Ingredient(s): Pancrelipase
FDA Approved: * May 17, 2012
Pharm Company: * DIGESTIVE CARE, INC
Category: Enzymes

Pancreatic enzymes, also known as pancreases or pancrelipase and pancreatin, are commercial mixtures of amylase, lipase, and protease.[1][2] They are used to treat malabsorption syndrome due to certain pancreatic problems.[1] These pancreatic problems may be due to cystic fibrosis, surgical removal of the pancreas, long term pancreatitis, or pancreatic cancer, among others.[1][3] The preparation is taken by mouth.... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Pertzye Oral Capsule, Delayed Release
NDC: 59767-004
Labeler:
Digestive Care, Inc.
Pertzye (Amylase 30,250 Unt / Lipase 8,000 Unt / Protease 28,750 Unt) Enteric Coated Capsule
NDC: 59767-008
Labeler:
Digestive Care, Inc.
Pertzye (Amylase 60,500 Unt / Lipase 16,000 Unt / Protease 57,500 Unt) Enteric Coated Capsule
NDC: 59767-016
Labeler:
Digestive Care, Inc.
Pertzye Oral Capsule, Delayed Release
NDC: 59767-024
Labeler:
Digestive Care, Inc.

Related Brands

Drugs with the same active ingredients